home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

'Rejuvenating' Neurons To Protect Against Parkinson's Disease

  June, 14 2007 19:55
your information resource in human molecular genetics
Encouraging neurons to revert to a more juvenile state might help slow or stop the progression of Parkinson's disease. Using mouse models of Parkinson's disease, James Surmeier and colleagues report that blocking calcium channels with a commonly used drug 'rejuvenates' the dopamine-containing neurons that are typically affected by the disorder.

Parkinson's disease is a neurodegenerative disorder characterized by the death of dopamine-containing neurons in a region of the brain called the substantia nigra - but why these neurons are particularly vulnerable remains unclear. This research shows that these neurons rely on calcium channels to maintain their rhythmic activity. This reliance increases with age and leads to sustained elevations in cytosolic Ca2+, which could ultimately be detrimental to the cells.By blocking calcium channels in adult neurons - in both in vitro and in vivo mouse models - the authors were able to induce a more juvenile form of neural activity, forcing the neurons to use other ion channels and protecting them against disease progression.

The authors, whose findings are published online in Nature, speculate that these findings point to a potential therapeutic strategy that might protect against Parkinson's disease in humans, and possibly also broaden the therapeutic window for patients in the early stages of the disease.

Author contact:

James Surmeier (Northwestern University, Chicago, IL, USA)
E-mail: j-Surmeier@northwestern.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.